The final analysis of a multicenter randomized controlled trial of gemcitabine (G) alone versus gemcitabine and S-1 combination therapy (GS) in patients with unresectable advanced pancreatic cancer (PC): GEMSAP study.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 4040-4040 ◽  
Author(s):  
H. Isayama ◽  
Y. Nakai ◽  
T. Sasaki ◽  
N. Sasahira ◽  
K. Hirano ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document